SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-24-000007
Filing Date
2024-01-30
Accepted
2024-01-30 07:48:56
Documents
18
Period of Report
2024-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20240128.htm   iXBRL 8-K 56949
2 EX-10.1 nickleschytransitionalserv.htm EX-10.1 54067
3 EX-10.2 a2seventybio-bairdwilliamx.htm EX-10.2 97129
4 EX-10.3 a2seventybio-eatwellvictor.htm EX-10.3 90351
5 EX-99.1 tsvtfirefoxpr_final1.htm EX-99.1 27983
  Complete submission text file 0001860782-24-000007.txt   523524

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20240128.xsd EX-101.SCH 2010
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20240128_lab.xml EX-101.LAB 24833
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20240128_pre.xml EX-101.PRE 13144
19 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20240128_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 24575879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)